Covaxin and Covishield (Jagran English)The central government has affirmed that the third booster dose of the Covid-19 vaccine is currently in scientific ideation stage and vaccinating the priority population is the primary focus as of now.
The total vaccination coverage crossed the 36 crore mark by Tuesday evening.
Balram Bhargava, Director General of the Indian Council of Medical Research (ICMR), told the Times of India, “The booster dose is still at the scientific ideation stage and efficacy is not proven.”
Bhargava further revealed that research is being conducted to discover the time period for which antibodies induced by vaccines persist in a body.
He mentioned that some studies have shown that antibodies in a patient who recovered from Covid-19 could last for 7-12 months. However, Bhargava asserted that no such clarity has been obtained regarding the antibodies developed through vaccines.
Until now, 46.2 per cent of people aged above 45 years in India have received at least a single dose of their Covid-19 vaccine. Similarly, around 17.2 per cent of individuals aged between 18-44 years have been given at least their first jab of the vaccine.
The nationwide vaccination program was re-centralized from 21st June and the overall coverage has expanded sharply since then.
An Appeal...
Dear Reader,
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.